STIM
Neuronetics·NASDAQ
--
--(--)
--
--(--)
STIM fundamentals
Neuronetics (STIM) Revenue Breakdown: Q3 2025 Business & Regional Performance
Neuronetics (STIM) reported total revenue of 37.30M USD in Q3 2025, with its core business segment Neurostar Advanced Therapy System contributing 10.61%. Regionally, United States remained the largest market, accounting for 97.19% of total revenue. Explore Neuronetics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Neuronetics (STIM) reported total revenue of 37.30M USD in Q3 2025, with its core business segment Neurostar Advanced Therapy System contributing 10.61%. Regionally, United States remained the largest market, accounting for 97.19% of total revenue. Explore Neuronetics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Neuronetics next quarter?What were the key takeaways from Neuronetics's earnings call?What factors drove the changes in Neuronetics's revenue and profit?What is the revenue and EPS growth rate for Neuronetics year over year?Did Neuronetics beat or miss consensus estimates last quarter?What is Neuronetics's latest dividend and current dividend yield?What guidance did Neuronetics's management provide for the next earnings period?What does Neuronetics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
